These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 20014976

  • 1. Atherosclerosis in systemic lupus erythematosus.
    Sherer Y, Zinger H, Shoenfeld Y.
    Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
    [Abstract] [Full Text] [Related]

  • 2. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S, Iaccarino L, Ghirardello A, Tarricone E, Arienti S, Sarzi-Puttini P, Gambari P, Doria A.
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [Abstract] [Full Text] [Related]

  • 3. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
    Narshi CB, Giles IP, Rahman A.
    Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
    [Abstract] [Full Text] [Related]

  • 4. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, Hörkkö S, Witztum JL.
    Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
    [Abstract] [Full Text] [Related]

  • 5. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN.
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [Abstract] [Full Text] [Related]

  • 6. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P, Atzeni F, Carrabba M.
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [Abstract] [Full Text] [Related]

  • 7. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
    Pompilian V, Badea C, Dragomanu I, Bălăşescu E, Tănăsescu C.
    Rom J Intern Med; 2008 Apr; 46(3):195-8. PubMed ID: 19366077
    [Abstract] [Full Text] [Related]

  • 8. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 9. SLE, atherosclerosis and cardiovascular disease.
    Frostegård J.
    J Intern Med; 2005 Jun; 257(6):485-95. PubMed ID: 15910552
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD.
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [Abstract] [Full Text] [Related]

  • 11. Vaccination, atherosclerosis and systemic lupus erythematosus.
    Carvalho JF, Pereira RM, Shoenfeld Y.
    Lupus; 2009 Nov; 18(13):1209-12. PubMed ID: 19880570
    [Abstract] [Full Text] [Related]

  • 12. Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies.
    Hahn BH, McMahon M.
    Lupus; 2008 May; 17(5):368-70. PubMed ID: 18490409
    [Abstract] [Full Text] [Related]

  • 13. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
    Abou-Raya A, Abou-Raya S.
    Autoimmun Rev; 2006 May; 5(5):331-7. PubMed ID: 16782558
    [Abstract] [Full Text] [Related]

  • 14. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.
    Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, Sarzi-Puttini P, Shoenfeld Y, Doria A.
    Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726
    [Abstract] [Full Text] [Related]

  • 15. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E.
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [Abstract] [Full Text] [Related]

  • 16. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of disease: atherosclerosis in autoimmune diseases.
    Sherer Y, Shoenfeld Y.
    Nat Clin Pract Rheumatol; 2006 Feb; 2(2):99-106. PubMed ID: 16932663
    [Abstract] [Full Text] [Related]

  • 18. Systemic lupus erythematosus and cardiovascular disease.
    Frostegård J.
    Lupus; 2008 May; 17(5):364-7. PubMed ID: 18490408
    [Abstract] [Full Text] [Related]

  • 19. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB, Godfrey T, Rowley KG, Karschimkus CS, Dragicevic G, Romas E, Clemens L, Wilson AM, Nikpour M, Prior DL, Best JD, Jenkins AJ.
    Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
    [Abstract] [Full Text] [Related]

  • 20. Premature atherosclerotic disease in systemic lupus erythematosus--role of inflammatory mechanisms.
    Rhew EY, Ramsey-Goldman R.
    Autoimmun Rev; 2006 Feb; 5(2):101-5. PubMed ID: 16431336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.